Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001373604-25-000029·BML Investment Partners, L.P.
Schedule 13G ownership disclosure
PMV PHARMACEUTICALS INC
Common Stock, $0.00001 par value per share · CUSIP: 69353Y103
Event date: 2024-12-31
- Filing-level shares
- 3,466,684
- Percent of class
- 6.7%
- BML Investment Partners, L.P.
Shares: 3,466,684 · Class: 6.7%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001373604-25-000029
- Form type
- SCHEDULE 13G/A
- Filer
- BML Investment Partners, L.P.
- CIK
- CIK 1373604
- Filed
- Feb 14, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership